Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hayden

Showing results (351-360 of 391) with videos related to

Pageof 40
Sort By:
The Lancet. Infectious Diseases|December 22, 2011
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectivesAeron C Hurt, Tawee Chotpitayasunondh, Nancy J Cox, et al.
The Journal of Infectious Diseases|March 18, 2000
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
The Journal of Infection|October 8, 2013
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirusJasper F W Chan, Kwok-Hung Chan, Richard Y T Kao, et al.
The Journal of Pediatrics|February 5, 2000
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
The Journal of Infectious Diseases|October 16, 2008
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individualsAnn R Falsey, Edward E Walsh, Jose Capellan, et al.
Frontiers of Medicine|July 5, 2020
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysisJiuyang Xu, Chaolin Huang, Guohui Fan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2016
New tools for studying microglia in the mouse and human CNSMariko L Bennett, F Chris Bennett, Shane A Liddelow, et al.
Emerging Infectious Diseases|August 18, 2016
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi ArabiaYaseen M Arabi, Ali H Hajeer, Thomas Luke, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2004
Clinical issues and research in respiratory failure from severe acute respiratory syndromeMitchell M Levy, Melisse S Baylor, Gordon R Bernard, et al.
Emerging Infectious Diseases|February 24, 2006
Influenza, Winter Olympiad, 2002Adi V Gundlapalli, Michael A Rubin, Matthew H Samore, et al.
Pageof 40

Showing results (351-360 of 391) with videos related to

Sort By:
Pageof 40
The Lancet. Infectious Diseases|December 22, 2011
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectivesAeron C Hurt, Tawee Chotpitayasunondh, Nancy J Cox, et al.
The Journal of Infectious Diseases|March 18, 2000
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
The Journal of Infection|October 8, 2013
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirusJasper F W Chan, Kwok-Hung Chan, Richard Y T Kao, et al.
The Journal of Pediatrics|February 5, 2000
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
The Journal of Infectious Diseases|October 16, 2008
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individualsAnn R Falsey, Edward E Walsh, Jose Capellan, et al.
Frontiers of Medicine|July 5, 2020
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysisJiuyang Xu, Chaolin Huang, Guohui Fan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2016
New tools for studying microglia in the mouse and human CNSMariko L Bennett, F Chris Bennett, Shane A Liddelow, et al.
Emerging Infectious Diseases|August 18, 2016
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi ArabiaYaseen M Arabi, Ali H Hajeer, Thomas Luke, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2004
Clinical issues and research in respiratory failure from severe acute respiratory syndromeMitchell M Levy, Melisse S Baylor, Gordon R Bernard, et al.
Emerging Infectious Diseases|February 24, 2006
Influenza, Winter Olympiad, 2002Adi V Gundlapalli, Michael A Rubin, Matthew H Samore, et al.
Pageof 40